Pharmacokinetics of the antiprogesterone RU 486 in women during multiple dose administration
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Journal of Steroid Biochemistry
- Vol. 32 (1) , 21-25
- https://doi.org/10.1016/0022-4731(89)90008-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Plasma concentrations and receptor binding of RU 486 and its metabolites in humansPublished by Elsevier ,2003
- Termination of early gestation with the anti-progestin steroid RU 486: Medium versus low doseContraception, 1987
- Termination of Early Pregnancy by the Progesterone Antagonist RU 486 (Mifepristone)New England Journal of Medicine, 1986
- Quantitation of RU 486 in human plasma by HPLC and RIA after column chromatographyContraception, 1986
- Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant womenContraception, 1986
- Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (Gemeprost)Contraception, 1986
- Pituitary-Adrenal Response to the Antiglucocorticoid Action of RU 486 in Cushing's Syndrome*Journal of Clinical Endocrinology & Metabolism, 1986
- Pregnancy termination with a high and medium dosage regimen of RU 486Contraception, 1986
- Successful Treatment of Cushing’s Syndrome with the Glucocorticoid Antagonist RU 486*Journal of Clinical Endocrinology & Metabolism, 1985
- Termination of very early pregnancy by RU 486 — An antiprogestational compoundContraception, 1984